vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and LIGHTPATH TECHNOLOGIES INC (LPTH). Click either name above to swap in a different company.

LIGHTPATH TECHNOLOGIES INC is the larger business by last-quarter revenue ($16.4M vs $14.7M, roughly 1.1× IRIDEX CORP). On growth, LIGHTPATH TECHNOLOGIES INC posted the faster year-over-year revenue change (120.2% vs -69.7%). Over the past eight quarters, LIGHTPATH TECHNOLOGIES INC's revenue compounded faster (45.7% CAGR vs 11.9%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

LightPath Technologies Inc designs, manufactures and distributes high-precision optical components and assemblies, including aspheric lenses, infrared optics, and fiber optic products. It serves global clients across industrial automation, aerospace, defense, medical imaging, and telecommunications sectors.

IRIX vs LPTH — Head-to-Head

Bigger by revenue
LPTH
LPTH
1.1× larger
LPTH
$16.4M
$14.7M
IRIX
Growing faster (revenue YoY)
LPTH
LPTH
+190.0% gap
LPTH
120.2%
-69.7%
IRIX
Faster 2-yr revenue CAGR
LPTH
LPTH
Annualised
LPTH
45.7%
11.9%
IRIX

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
IRIX
IRIX
LPTH
LPTH
Revenue
$14.7M
$16.4M
Net Profit
$-9.4M
Gross Margin
37.2%
36.8%
Operating Margin
-52.6%
Net Margin
-57.5%
Revenue YoY
-69.7%
120.2%
Net Profit YoY
-260.1%
EPS (diluted)
$-0.20

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
LPTH
LPTH
Q4 25
$14.7M
$16.4M
Q3 25
$12.5M
$15.1M
Q2 25
$13.6M
$12.2M
Q1 25
$11.9M
$9.2M
Q4 24
$12.7M
$7.4M
Q3 24
$11.6M
$8.4M
Q2 24
$12.6M
$8.6M
Q1 24
$11.8M
$7.7M
Net Profit
IRIX
IRIX
LPTH
LPTH
Q4 25
$-9.4M
Q3 25
$-1.6M
$-2.9M
Q2 25
$-994.0K
$-7.1M
Q1 25
$-1.7M
$-3.6M
Q4 24
$-834.0K
$-2.6M
Q3 24
$-1.9M
$-1.6M
Q2 24
$-2.7M
$-2.4M
Q1 24
$-3.5M
$-2.6M
Gross Margin
IRIX
IRIX
LPTH
LPTH
Q4 25
37.2%
36.8%
Q3 25
32.1%
29.8%
Q2 25
34.5%
22.0%
Q1 25
42.5%
29.1%
Q4 24
44.0%
26.0%
Q3 24
37.3%
33.9%
Q2 24
40.7%
29.2%
Q1 24
37.9%
20.9%
Operating Margin
IRIX
IRIX
LPTH
LPTH
Q4 25
-52.6%
Q3 25
-11.3%
-16.6%
Q2 25
-6.9%
-38.0%
Q1 25
-1.7%
-36.3%
Q4 24
-3.9%
-33.5%
Q3 24
-16.1%
-16.4%
Q2 24
-20.9%
-25.6%
Q1 24
-28.0%
-33.6%
Net Margin
IRIX
IRIX
LPTH
LPTH
Q4 25
-57.5%
Q3 25
-12.6%
-19.2%
Q2 25
-7.3%
-57.8%
Q1 25
-14.2%
-39.1%
Q4 24
-6.6%
-35.2%
Q3 24
-16.7%
-19.3%
Q2 24
-21.2%
-27.3%
Q1 24
-29.5%
-33.7%
EPS (diluted)
IRIX
IRIX
LPTH
LPTH
Q4 25
$-0.20
Q3 25
$-0.09
$-0.07
Q2 25
$-0.06
$0.19
Q1 25
$-0.10
$-0.44
Q4 24
$-0.05
$-0.07
Q3 24
$-0.12
$-0.04
Q2 24
$-0.16
$-0.15
Q1 24
$-0.21
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
LPTH
LPTH
Cash + ST InvestmentsLiquidity on hand
$6.0M
$73.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$77.9M
Total Assets
$29.2M
$148.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
LPTH
LPTH
Q4 25
$6.0M
$73.6M
Q3 25
$5.6M
Q2 25
$6.8M
$4.9M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$4.1M
Q1 24
$5.4M
Total Debt
IRIX
IRIX
LPTH
LPTH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
Q3 24
$1.4M
Q2 24
$535.0K
Q1 24
$599.4K
Stockholders' Equity
IRIX
IRIX
LPTH
LPTH
Q4 25
$77.9M
Q3 25
$4.7M
$21.4M
Q2 25
$6.1M
$15.6M
Q1 25
$852.0K
$15.7M
Q4 24
$2.1M
$26.7M
Q3 24
$2.6M
$29.4M
Q2 24
$4.2M
$30.2M
Q1 24
$6.5M
$31.7M
Total Assets
IRIX
IRIX
LPTH
LPTH
Q4 25
$29.2M
$148.6M
Q3 25
$28.4M
$87.3M
Q2 25
$31.6M
$81.5M
Q1 25
$34.2M
$81.4M
Q4 24
$29.1M
$45.8M
Q3 24
$30.2M
$48.4M
Q2 24
$31.2M
$48.1M
Q1 24
$34.1M
$49.7M
Debt / Equity
IRIX
IRIX
LPTH
LPTH
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
Q3 24
0.53×
Q2 24
0.02×
Q1 24
0.02×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
LPTH
LPTH
Operating Cash FlowLast quarter
$2.8M
Free Cash FlowOCF − Capex
$2.0M
FCF MarginFCF / Revenue
12.0%
Capex IntensityCapex / Revenue
5.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-6.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
LPTH
LPTH
Q4 25
$2.8M
Q3 25
$-1.2M
$-1.1M
Q2 25
$-397.0K
$-2.6M
Q1 25
$-1.1M
$-3.2M
Q4 24
$-1.2M
$-737.4K
Q3 24
$-3.1M
$-1.7M
Q2 24
$-1.3M
$64.7K
Q1 24
$-1.6M
$-394.2K
Free Cash Flow
IRIX
IRIX
LPTH
LPTH
Q4 25
$2.0M
Q3 25
$-1.2M
$-1.2M
Q2 25
$-410.0K
$-3.3M
Q1 25
$-1.2M
$-3.7M
Q4 24
$-1.2M
$-817.8K
Q3 24
$-3.1M
$-1.8M
Q2 24
$-225.5K
Q1 24
$-1.7M
$-802.5K
FCF Margin
IRIX
IRIX
LPTH
LPTH
Q4 25
12.0%
Q3 25
-9.4%
-8.1%
Q2 25
-3.0%
-27.3%
Q1 25
-9.8%
-40.0%
Q4 24
-9.8%
-11.0%
Q3 24
-26.5%
-21.2%
Q2 24
-2.6%
Q1 24
-14.0%
-10.4%
Capex Intensity
IRIX
IRIX
LPTH
LPTH
Q4 25
5.3%
Q3 25
0.1%
0.5%
Q2 25
0.1%
5.6%
Q1 25
0.1%
4.6%
Q4 24
0.1%
1.1%
Q3 24
0.0%
0.9%
Q2 24
0.0%
3.4%
Q1 24
0.0%
5.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRIX
IRIX

Segment breakdown not available.

LPTH
LPTH

Other$7.9M48%
Infrared Components$5.0M31%
Visible Components$3.4M21%

Related Comparisons